Hospitalogy July 23, 2024
Blake Madden

After expecting to price its IPO in the $20-$22 share range and raising just south of $300M net of fees, Ardent Health instead raised $192M at a $16 share price in its debut on the public markets.

While Ardent has held its weight so far on the public markets (trading up 12% to north of $17/share), the relatively muted debut leaves me wondering what the investor appetite is like for upcoming IPOs. There are a few different factors at play here, including lack of large scale exits / M&A, potential interest rate cuts on the horizon, oh…and of course, that whole Presidential election thing.

...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Investments, Mergers & Acquisitions / JV, Trends
[UPDATED] CareTrust REIT Announces Recommended Cash Offer of $817M for Care REIT
Scoop: Trump FTC tells CEOs when agency will "get the hell out of the way" on M&A
FTC sues to block merger of device coatings companies
CareTrust Subsidiary to Acquire UK-Based REIT, 137 Properties for $817M
Bristol Myers Squibb Buys Out Cancer Cell Therapy Partner 2seventy Bio in $286M Deal

Share This Article